These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31010486)

  • 1. Male PCOS equivalent and nutritional restriction: Are we stepping forward?
    Di Guardo F; Cerana MC; D'urso G; Genovese F; Palumbo M
    Med Hypotheses; 2019 May; 126():1-3. PubMed ID: 31010486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does a male polycystic ovarian syndrome equivalent exist?
    Cannarella R; Condorelli RA; Mongioì LM; La Vignera S; Calogero AE
    J Endocrinol Invest; 2018 Jan; 41(1):49-57. PubMed ID: 28711970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic, and Clinical Aspects.
    Di Guardo F; Ciotta L; Monteleone M; Palumbo M
    Int J Fertil Steril; 2020 Jul; 14(2):79-83. PubMed ID: 32681618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
    Starka L; Duskova M; Cermakova I; Vrbiková J; Hill M
    Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome.
    Stárka L; Dušková M
    Prague Med Rep; 2021; 122(2):73-79. PubMed ID: 34137683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What may be the markers of the male equivalent of polycystic ovary syndrome?
    Dusková M; Cermáková I; Hill M; Vanková M; Sámalíková P; Stárka L
    Physiol Res; 2004; 53(3):287-94. PubMed ID: 15209536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in the polycystic ovary syndrome.
    Dunaif A; Thomas A
    Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study.
    Matilainen V; Laakso M; Hirsso P; Koskela P; Rajala U; Keinänen-Kiukaanniemi S
    J Cardiovasc Risk; 2003 Jun; 10(3):227-31. PubMed ID: 12775957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome in adolescents.
    Franks S
    Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN; Schulte N; Sonntag B; Kiesel L
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.